Oct 24- Banana producer Chiquita Brands International Inc said it would start takeover talks with Brazil's Grupo Cutrale and Safra Group after its shareholders voted against a proposed merger with Irish rival Fyffes Plc. Fyffes' shares fell 5 percent to 94 euro cents in Dublin after the collapse of the deal, which would have created a company domiciled in...» Read More
May 1- Pfizer Inc and AstraZeneca Plc have resumed talks about a trans-Atlantic merger of the two drug giants after Pfizer sweetened the terms of an earlier takeover offer for its British rival, the Wall Street Journal reported, citing people familiar with the matter.
May 1- Investment bank and asset manager Lazard Ltd more than doubled its adjusted quarterly profit as its merger advisory revenue soared in a thriving M&A market. Lazard's financial advisory revenue soared 64 percent to $275.5 million in the first quarter ended March 31, driven by a doubling of M&A and other advisory fees.
As rivals assessed what Pfizer's play for AstraZeneca could mean for the industry, one aspect touched nearly everyone: What it could mean for a U.S. tax loophole.
LONDON/ NEW YORK/ PARIS, May 1- Publicis and Omnicom have lost more than $1.5 billion of client work in recent weeks and face a fight to retain billions more, including a huge Samsung contract, just as the two advertising firms struggle to keep their merger on track.
Wells Fargo's Bonnie Herzog thinks a Lorillard-Reynolds merger would make a profitable combination, reports CNBC's David Faber.
LONDON, April 29- European stocks rose on Tuesday, lifted by well-received corporate earnings and merger and acquisition activity as investors pushed mixed signals on the European Central Bank policy outlook and crisis in Ukraine onto the back burner.
April 29- Alliant Techsystems Inc said it would merge its aerospace and defense business with Orbital Sciences Corp in stock. Alliant Techsystems said its shareholders will own about 53.8 percent of the combined company, with Orbital shareholders holding the rest. Alliant also said it would spin off its outdoor sports business.
April 29- American Realty Capital Properties Inc and NorthStar Realty Finance Corp said they were not currently in merger talks, a day after reports that American Realty was looking to buy the real estate financing company.
LONDON, April 29- European stocks rose on Tuesday, as optimism surrounding corporate earnings and merger moves eclipsed the crisis in Ukraine, while rising euro zone money market rates and strong German consumer confidence supported the euro.
Goodman Fielder said it has received a A$1.3 billion ($1.2 billion) bid from Wilmar International but that the offer undervalues the company.
General Electric is in talks with Alstom to take over its global power business. A deal could be announced in days, two sources said.
Medical device maker Zimmer Holdings said it would buy orthopedic products company Biomet to broaden its portfolio of products that treat bone and joint-related disorders.
Drugmakers eager to satisfy shareholders are wheeling, dealing, and in one case even making trades like a pro sports team looking to shake up its roster.
Comcast may divest about 4 million subscribers after its merger with Time Warner Cable and may sell a portion to Charter Communications.
CNBC's Patti Domm discusses the amount of merger activity happening this week with a big three-way deal in the drug industry, and the $46 billion bid by Valeant and activist Bill Ackman for Allergan.
Walgreen's pending acquisition of Alliance Boots can mean lower taxes and a better company, according to activist investor Barry Rosenstein.
"Shark Tank" investor Kevin O'Leary discusses recent mergers between pharmaceutical companies.
Valeant Pharmaceuticals and Bill Ackman are proposing a cash-and-stock deal for Allergan that could be worth about $45 billion.
Netflix announced it intends to raise its membership price for new subscribers, and Netflix CEO Reed Hastings remarked on the proposed Comcast and Time Warner Cable deal during the webcast, with the "Squawk Box" crew.
Pharmaceutical industry observers have been waiting for a rush of deals for months - and they might have finally arrived.